Sproutly Receives Research License from Heath Canada /NOT FOR DISSEMINATION IN THE US OR THROUGH US NEWSWIRE SERVICES/
VANCOUVER, BC, April 13, 2022 /CNW/ - Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) ("Sproutly" or the "Company"), is pleased to announce that the company's wholly-owned subsidiary, Toronto Herbal Remedies Inc. ("THR"), a licenced producer under the Cannabis Act, has received a research licence from Health Canada effective April 11, 2022. The licence allows THR to evaluate the ingredients produced by the proprietary APP technology and product formulations incorporating these ingredients.
https://www.newswire.ca/en/releases/archive/April2022/13/c8042.html